Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.17% | -1.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.17% | -1.12% | |||
| Cost of Revenue | -4.72% | 2.76% | |||
| Gross Profit | -3.83% | -3.38% | |||
| SG&A Expenses | -9.28% | 10.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.90% | 6.32% | |||
| Operating Income | 108.58% | -74.58% | |||
| Income Before Tax | 1,421.04% | 120.79% | |||
| Income Tax Expenses | -70.03% | 1,500.18% | |||
| Earnings from Continuing Operations | 166.66% | -324.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 166.66% | -324.46% | |||
| EBIT | 108.58% | -74.58% | |||
| EBITDA | 0.61% | -20.49% | |||
| EPS Basic | 166.34% | -323.71% | |||
| Normalized Basic EPS | 1,413.02% | 120.77% | |||
| EPS Diluted | 164.98% | -321.94% | |||
| Normalized Diluted EPS | 1,389.06% | 120.77% | |||
| Average Basic Shares Outstanding | 0.48% | 0.18% | |||
| Average Diluted Shares Outstanding | 2.10% | 0.18% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.51% | 0.76% | |||